Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.
Rehab AlblooshiSolaf KanfarBridgette LordEshetu G AtenafuFotios V MichelisIvan PasicArmin GerbitzZeyad Al-ShaibaniAuro ViswabandyaDennis Dong Hwan KimWilson LamArjun LawJonas MattssonRajat KumarJeffrey Howard LiptonPublished in: European journal of haematology (2020)
A history of CV disease, MI, or CAD was the most important predictive of CV events, P-value = .00002. 88.6% survived the first 100 days. Patients with an EF < 50% had a significant likelihood of having a CV event compared to patients with an EF > 60% (OR = 5.3, 95% CI [1.6-18.1], P = .0219). Cumulative anthracycline dose did not have a significant impact on overall survival.